BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced that its Chief Financial Officer, Sylvia Cheung, will participate in the following upcoming investor conferences:
• Barrington Research Fall Investment Conference on Thursday, September 8, 2016. The conference consists of 1:1 meetings, and it is being held at the Four Seasons hotel in Chicago.
• Barrington Research Fall Investment Conference on Thursday, September 8, 2016. The conference consists of 1:1 meetings, and it is being held at the Four Seasons hotel in Chicago.
